Editor,—I have read with interest the paper by Foley-Nolan et al 1 on the use of atropine as an alternative to occlusion for treating amblyopia. Presumably all the patients entering their trial had strabismus, otherwise there would not have been suppression but some degree of normal binocularity. It should be pointed out that the daily instillation of atropine into the fixing eye, as advocated by Worth,2 may be …